+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ovarian"

Polycystic Ovary Syndrome- Pipeline Insight, 2025 - Product Thumbnail Image

Polycystic Ovary Syndrome- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Uterine Fibroids - Pipeline Insight, 2025 - Product Thumbnail Image

Uterine Fibroids - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
Polycystic Ovary Syndrome Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Polycystic Ovary Syndrome Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Femtech Market Report and Forecast 2025-2034 - Product Thumbnail Image

Femtech Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
Gynaecology Drugs Market Report and Forecast 2025-2034 - Product Thumbnail Image

Gynaecology Drugs Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
From
From
From
From
From
From
From
Loading Indicator

The Ovarian market is a segment of the Women's Health industry that focuses on the diagnosis, treatment, and prevention of ovarian diseases. It includes products and services related to the diagnosis, treatment, and prevention of ovarian cancer, ovarian cysts, and other ovarian disorders. The market also includes products and services related to fertility, contraception, and hormone replacement therapy. The Ovarian market is driven by the increasing prevalence of ovarian diseases, the growing awareness of the importance of early diagnosis and treatment, and the increasing demand for fertility treatments. Additionally, the development of new technologies and treatments for ovarian diseases is expected to drive the market growth. Some companies in the Ovarian market include AbbVie, AstraZeneca, Bayer, Merck, Novartis, Pfizer, and Roche. Show Less Read more